CB-103
CB-103 + lenvatinib or abemaciclib
Cellestia Biotech · Phase 1/2 · Recruiting · Enrollment 32
| Arm | Reported safety |
|---|
A count stays a count. This page does not turn a count into a percent.
ACC
Programs, trials, and reported response and survival for adenoid cystic carcinoma.
CB-103
Cellestia Biotech · Phase 1/2 · Recruiting · Enrollment 32
| Arm | Reported safety |
|---|
A count stays a count. This page does not turn a count into a percent.